⚙️ Application & Function
Ticagrelor is a novel antiplatelet drug commonly used in the treatment of arterial thrombotic diseases, focusing on inhibiting platelet aggregation and preventing thrombosis. It is widely applied in the treatment and secondary prevention of acute coronary syndrome (including unstable angina pectoris, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction).
Combined with aspirin, it can form a dual antiplatelet regimen, significantly improving the long-term prognosis of patients. Its mechanism specifically and reversibly binds to the P2Y12 receptor, blocking adenosine diphosphate (ADP)-mediated platelet activation. After drug withdrawal, platelet function can quickly recover, reducing the risk of bleeding compared to irreversible inhibitors.
❓ Frequently Asked Questions
What is the purity of your Ticagrelor powder?
Our Ticagrelor powder maintains a high purity level of over 99%, as verified by HPLC testing.
What are the primary applications for this material?
It is primarily used as an active pharmaceutical ingredient (API) for treating acute coronary syndromes and preventing thrombotic events.
Does this product meet international standards?
Yes, the product is manufactured under GMP conditions and complies with USP, BP, and ISO 9001 standards.
How does Ticagrelor differ from other antiplatelet agents?
Ticagrelor binds reversibly to the P2Y12 receptor, allowing for faster recovery of platelet function after discontinuation compared to irreversible agents.
What is the typical appearance and storage state?
It is a white or almost white crystalline powder. It should be stored according to standard pharmaceutical raw material protocols to maintain stability.
What is your monthly production capacity?
We have a stable production capacity of approximately 1000kg per month to meet large-scale industrial needs.
SJ Medical
